Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy

Full text
Author(s):
Andrade, Valeria C. C. ; Vettore, Andre L. [1] ; Panepucci, Rodrigo A. [2] ; Almeida, Manuella S. S. ; Yamamoto, Mihoko ; De Carvalho, Fabricio ; Caballero, Otavia L. [3] ; Zago, Marco Antonio [3] ; Colleoni, Gisele W. B. [4]
Total Authors: 9
Affiliation:
[1] Univ Fed Sao Paulo, Dept Biol, Diadema - Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo - Brazil
[3] Ludwig Inst Canc Res, New York Branch, New York, NY - USA
[4] Univ Fed Sao Paulo, EPM, Discipline Hematol & Hemotherapy, BR-04023900 Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Leukemia & Lymphoma; v. 51, n. 8, p. 1543-1549, AUG 2010.
Web of Science Citations: 3
Abstract

Considering that the importance of cancer/testis (CT) antigens in multiple myeloma (MM) biology is still under investigation, the present study aimed to: (1) identify genes differentially expressed in MM using microarray analysis of plasma cell samples, separated according to the number of expressed CTs; (2) examine possible pathways related to MM pathogenesis; (3) validate the expression of candidate genes by quantitative real-time PCR (RQ-PCR). Three samples predominantly positive (>6 expressed), including the U266 cell line, and three samples predominantly negative (0 or 1 expressed CT for the 13 analyzed CT antigens), were submitted for microarray analysis. Validation by RQ-PCR from 24 MM samples showed that the ITGAS gene was downregulated in predominantly positive (>6 expressed CTs, p = 0.0030) and in tumor versus normal plasma cells (p = 0.0182). The RhoD gene was overexpressed in tumor plasma cells when compared to normal plasma cells (p = 0.0339). Results of the microarray analysis corroborate the hypothesis that MM could be separated into predominantly positive and predominantly negative expression. The differential expression of ITGA5 and RhoD suggests disruption of the focal adhesion pathway in MM and offers a new target field to be explored in this disease. (AU)